Nitric oxide and asthma: A review

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 1, 2000, Pages 21-25

  Ashutosh, Kumar ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARGININE; CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STEROID;

AIR ANALYSIS; ASTHMA; BRONCHOSPASM; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DISEASE MARKER; EOSINOPHILIA; EXPIRED AIR; HUMAN; INFLAMMATION; PATHOGENESIS; REVIEW; STANDARDIZATION;

EID: 0033826963     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200001000-00005     Document Type: Review

References (60)

1. Properties and oxidative regulation of guanylate cyclase
2. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide
3. Nitric oxide and the lung. NHLBI Workshop Summary
4. Nitric oxide, the biological mediator of the decade: Fact or fiction?
5. Nitric oxide and lung disease
6. Nitric oxide: A physiologic messenger
7. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
8. EPR demonstration of iron nitrosyl complex formation by cytotoxic activated macrophages
9. Nonspecific defense mechanism: The role of nitric oxide
10. Macrophage cytotoxicity: Role for L-Arginine deiminase and lumino nitrogen oxidation to nitrite
11. Physiological significance of endogenous nitric oxide
12. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure
13. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages
14. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways
15. Bronchodilator effect of inhaled nitric oxide in healthy men
16. Inhaled nitric oxide: A bronchodilator in mild asthmatics with methacholine induced bronchospasm
17. Inhalation of nitric oxide modulates adult human bronchial tone
18. Time course and dose response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
19. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension
20. NO or no NO in asthma
21. The role of nitric oxide in the development of asthma
22. Regulation of the immune response by nitric oxide differentially produced by T-helper type 1 and T-helper type 2 cells
23. Effects of nitric oxide inhalation for twenty four hours in oxygen dependent patients with chronic obstructive pulmonary disease
24. Worsening of pulmonary gas exchange with NO inhalation in chronic obstructive pulmonary disease
25. Nitric oxide in exhaled breath in humans: Direct CC-MS confirmation
26. Measurement of exhaled nitric oxide in man
27. Elevated nitric oxide concentration in isolated lower airway gas of asthmatic subject
28. Single breath nitric oxide measurement in asthmatic patient and smokers
29. Increased nitric oxide in exhaled air of asthmatic normal subjects with upper respiratory tract infections
30. Elevated levels of exhaled nitric oxide in bronchiectasis
31. Exhaled nitric oxide in human lung transplantation: A non-invasive marker of acute rejection
32. Endogenous nitric oxide in patients with stable COPD: Correlates with severity of disease
33. Increased nitric oxide in exhaled air of asthmatic subjects
34. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with asthma
35. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids
36. Folkerts G-Nitric oxide and bronchial hyperresponsiveness
37. Estrogen acutely stimulates endothelial nitric oxide in human epithelial cells
38. Exhaled nitric oxide is reduced shortly after bronchoconstriction to direct and indirect stimuli
39. Can exhaled NO be used as a marker of airway inflammation?
40. Expired nitric oxide levels during treatment of acute asthma
41. Exhaled nitric oxide as a non-invasive assessment of chronic cough
42. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
43. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild intermittent asthma
44. Exhaled nitric oxide concentration during treatment of wheezing exacerbation in infants and young children
45. Exhaled and nasal NO levels in allergic rhinitis: Relation to sensitization, pollen season and bronchial hyperresponsiveness
46. Exhaled nitric oxide measurements in a population of young adults
47. Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation
48. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma
49. Airway inflammation, exhaled nitric oxide and severity of asthma in patients with western red cedar asthma
50. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma
51. Exhaled nitric oxide is not elevated in the inflammatory airways disease of cystic fibrosis and bronchiectasis
52. Exhaled nitric oxide in relationship to clinicophysiological markers of asthma severity
53. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbation with gluco-corticoids in children
54. Water vapor and carbon dioxide decrease nitric oxide readings
55. High nitric oxide production in human paranasal sinuses: Primary nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome
56. Nonenzymatic nitric oxide production in humans
57. Exhaled and nasal nitric oxide measurements: Recommendations-ERS task force report
58. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoids